Your session is about to expire
← Back to Search
Endovascular Repair for Aortic Disease
Study Summary
This trial is testing whether a physician-modified Medtronic Thoracic Valiant stent graft is effective in treating complex thoracoabdominal aortic lesions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a condition that could infect my heart valve or stent.My aorta near my heart fits the required size and shape for a safe procedure.I have a complex aortic lesion and am eligible for a non-surgical repair procedure.You need to have a specific type of access in your body that can work with a certain medical device.I am not pregnant and I am 21 years old or older.You are not expected to live for more than a year.You are allergic to the material used in the stent graft.My iliac artery is wider than 12mm and longer than 2cm.My left subclavian artery can safely accommodate an 8 mm conduit.
- Group 1: Endovascular Device Implantation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still openings for participation in this medical trial?
"As per clinicaltrials.gov, the current recruitment period for this medical study commenced on July 1st 2015 and was last updated in March 11th 2022."
Is it feasible for me to take part in this scientific investigation?
"This medical trial is looking for 15 individuals between the age of 21 and 90 with aortic diseases. Additionally, these participants must meet the following criteria: An angle less than 60° relative to axis of the thoracic aorta; Type IV complex thoracoabdominal aortic lesion amenable to endovascular repair; ileofemoral access compatible with delivery of 25 Fr MedtronicValiant thoracic endograft ; left subclavian artery anatomy that allows 8 mm Dacron conduit antegrade deployments; nonaneurysmal proximal aortic segment distal to left"
How many individuals are enrolled in the current trial?
"Affirmative, the information provided on clinicaltrials.gov indicates that this research endeavour is actively looking for participants. The study has been visible since July 1st 2015 and was most recently edited March 11th 2022; 15 patients are required between two different locations."
Is this research protocol accessible to persons younger than 65 years of age?
"The age range of participants accepted into this study extends from their 21st birthday up to 90 years old."
Share this study with friends
Copy Link
Messenger